The effects of beauverficin, a cyclodepsipeptide compound, on ion currents in a mouseneuroblastoma and rat glioma hybrid cell line, NG108-15, were investigated with the aid ofthe whole-cell voltage-clamp technique. Beauvericin (0.3-100
![](/images/entities/mgr.gif)
M) reversibly produced aninhibition of L-type voltage-dependent Ca
2+ current (
ICa,L) in a concentration-dependent manner.Beauvericin caused no change in the overall shape of the current-voltage relationship of
ICa,L.The IC
50 value of beauvericin-induced inhibition of
ICa,L was 4
![](/images/entities/mgr.gif)
M. Neither gabapentin (30
![](/images/entities/mgr.gif)
M) nor
![](/images/gifchars/omega.gif)
-conotoxin GVIA (3
![](/images/entities/mgr.gif)
M) had effects on
ICa,L. Beauvericin (30
![](/images/entities/mgr.gif)
M) shifted the steady-state inactivation curve of
ICa,L to more negative membrane
potentials by approximately -15mV. The inhibitory effects of beauvericin on
ICa,L exhibited tonic and use-dependent characteristics. Beauvericin also suppressed
ICa,L evoked by repetitive action potential waveformseffectively. However, beauvericin (30
![](/images/entities/mgr.gif)
M) had no effect on delayed rectifier K
+ current inNG105-18 cells. Under current-clamp configuration, beauvericin reduced the firing frequencyof action
potentials. Therefore, this study indicates that beauvericin is a relatively specificinhibitor of L-type Ca
2+ current in NG108-15 cells.